{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37
  ],
  "modelUsed": "gemini-3-flash-preview",
  "eligibility": {
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Informed Consent",
        "text": "Signed written Informed Consent: Subjects or their legally responsible representatives must be willing and able to give signed and dated written informed consent",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "Diagnosis of T1DM",
        "text": "Diagnosis of T1DM. In addition, the following criteria also needs to be met; i) Central laboratory test of C-peptide < 0.7 ng/ml (0.23 nmol/L)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Insulin Use",
        "text": "Insulin use for at least 12 months prior to screening per subject report or medical records and a) Method of insulin administration (MDI or CSII) must have been unchanged for at least 3 months prior to the screening visit per subject reported or medical records. Subjects must be taking a total insulin dose of ≥0.3 U/kg/day for at least 3 months prior to the screening visit b) If on MDI insulin administration, subject must be taking ≥3 injections per day",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "HbA1c Eligibility",
        "text": "HbA1c eligibility criteria include: a) Screening visit: Central laboratory HbA1c ≥7.7% and ≤11.0% b) Week -1 Visit: Central laboratory HbA1c ≥7.5 % and ≤10.5%",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "BMI Requirement",
        "text": "Body mass index (BMI) ≥18.5 kg/m²",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "Age and Reproductive Status",
        "text": "Men and women, ages 18 to 75 years, inclusive. Women of childbearing potential (WOCBP) must have a negative serum or urine pregnancy test within 24 hours prior to the start of investigational product. Women must not be breastfeeding. WOCBP and sexually active males must agree to follow instructions for method(s) of contraception.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "History of T2DM",
        "text": "History of T2DM. Note: subjects with a previous misdiagnosis of T2DM in their medical history must have one of the following in order to be eligible for this trial: Positive autoantibodies for GAD65, phosphatase IA-2/IA2β, or zinc transporter 8 (ZnT8) or Fasting c-peptide value below the lower limit of detection performed by the Central Laboratory",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "MODY History",
        "text": "History of maturity-onset diabetes of the young (MODY)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Pancreatic Disorders",
        "text": "Pancreatic surgery, chronic pancreatitis, or other pancreatic disorders that could result in decreased β-cell capacity (eg, pancreatogenous diabetes)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Previous SGLT-2 Use",
        "text": "Previous use of dapagliflozin and/or any other SGLT-2 inhibitors",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Insulin-sensitizing Agents",
        "text": "Use of insulin-sensitizing agents, such as metformin and/or thiazolidinediones, within 2 months prior to the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "GLP-1 Receptor Agonist Use",
        "text": "Use of any GLP-1 receptor agonist within the following timeframe prior to the screening visit: 1 month for once or twice daily administration (eg, liraglutide); 2 months for once weekly administration",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_13",
        "name": "Non-insulin Antihyperglycemic Use",
        "text": "Use of any non-insulin antihyperglycemic agent within 1 month prior to the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_14",
        "name": "History of DKA",
        "text": "History of DKA requiring medical intervention (eg, emergency room visit and/or hospitalization) within 1 month prior to the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_15",
        "name": "Hospital Admission for Glycemic Control",
        "text": "History of hospital admission for glycemic control (either hyperglycemia or hypoglycemia) within 1 month prior to the Screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_16",
        "name": "Severe Hypoglycemia Episodes",
        "text": "Frequent episodes of severe hypoglycemia as defined by more than one episode requiring medical assistance, emergency care (paramedics or emergency room care), and/or glucagon therapy administered by a third-party individual within 1 month prior to the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_17",
        "name": "Poorly Controlled Diabetes Symptoms",
        "text": "Symptoms of poorly controlled diabetes that would preclude participation in this trial including, but not limited to, marked polyuria and polydipsia with greater than 10% weight loss during the 3 months prior to the screening visit, or other signs and symptoms of poor glycemic control",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_18",
        "name": "Addison's or Adrenal Insufficiency",
        "text": "History of Addison’s disease or chronic adrenal insufficiency",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_19",
        "name": "Diabetes Insipidus",
        "text": "History of diabetes insipidus",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_20",
        "name": "Cardiovascular Disease",
        "text": "Any of the following cardiovascular (CV)/vascular disease within 6 months of the screening visit: Myocardial infarction, Cardiac surgery or revascularization, Unstable angina, Unstable congestive heart failure (CHF), NYHA CHF Class III or IV, TIA or significant cerebrovascular disease, Unstable or previously undiagnosed arrhythmia",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_21",
        "name": "Renal Disease",
        "text": "Renal disease: History of unstable or rapidly progressing renal disease; Conditions of congenital renal glucosuria; Renal allograft",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_22",
        "name": "Hepatic Diseases",
        "text": "Significant hepatic disease, including, but not limited to, chronic active hepatitis and/or severe hepatic insufficiency",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_23",
        "name": "Hematological and Oncological Disease",
        "text": "History of hemoglobinopathy (except sickle cell trait or thalassemia minor); Known immunocompromised status; Donation of blood > 400 mL within 8 weeks; Malignancy within 5 years; History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_24",
        "name": "Liver Function Tests",
        "text": "Aspartate aminotransferase (AST) > 3x ULN; Alanine aminotransferase (ALT) > 3x ULN; Serum total bilirubin (TB) > 2x ULN unless exclusively caused by Gilbert’s Syndrome",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_25",
        "name": "Creatinine Clearance",
        "text": "Calculated creatinine clearance (CrCl) < 60 mL/min as estimated by the Cockcroft-Gault formula at the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_26",
        "name": "Hemoglobin Levels",
        "text": "Hemoglobin ≤11.0 g/dL (110 g/L) for men; hemoglobin ≤10.0 g/dL (100 g/L) for women",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_27",
        "name": "Hepatitis Status",
        "text": "Positive for hepatitis B surface antigen or anti-hepatitis C virus antibody",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_28",
        "name": "Abnormal Free T4",
        "text": "Abnormal Free T4 (abnormal TSH value at enrollment will be further evaluated for free T4)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_29",
        "name": "Allergies",
        "text": "Allergies or contraindication to the contents of dapagliflozin tablets or insulin",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_30",
        "name": "Pregnancy/Breastfeeding",
        "text": "Women who are pregnant or breastfeeding",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_31",
        "name": "Incarceration",
        "text": "Prisoners or subjects who are involuntarily incarcerated; Subjects who are compulsorily detained for treatment of either a psychiatric or physical illness",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_32",
        "name": "Weight Loss/Exercise Programs",
        "text": "Subjects on a commercial weight loss program with ongoing weight loss, or on an intensive exercise program; History of bariatric surgery or lap-band procedure within 12 months prior to screening",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_33",
        "name": "Corticosteroid Therapy",
        "text": "Replacement or chronic systemic corticosteroid therapy, defined as any dose of systemic corticosteroid (including local injections) taken for > 4 weeks within 3 months prior to the Day 1 visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_34",
        "name": "Unstable Disorders",
        "text": "Any unstable endocrine, psychiatric or rheumatic disorders as judged by the investigator",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_35",
        "name": "Volume Depletion",
        "text": "Volume-depleted subjects. Subjects at risk for volume depletion due to co-existing conditions or concomitant medications who cannot carefully monitor their volume status",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_36",
        "name": "Compliance and Medical Judgment",
        "text": "Subject who, in the judgment of the investigator, is found to be unlikely to comply with the protocol, or is unable to correctly administer subcutaneous insulin injections and/or manage their insulin pump, or has any severe concurrent medical or psychological condition",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_37",
        "name": "Substance Abuse",
        "text": "Subject is currently abusing alcohol or other drugs or has done so within the last 6 months prior to the Day 1 visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_38",
        "name": "Investigator/Employee Conflict",
        "text": "Subject is a participating investigator, study coordinator, employee of an investigator, or employee of BMS/AstraZeneca",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_39",
        "name": "Other Investigational Drug",
        "text": "Administration of any other investigational drug within 30 days of the screening visit",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "identifier": "1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion",
        "name": "Informed Consent",
        "nextId": "ec_2"
      },
      {
        "id": "ec_2",
        "identifier": "2",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion",
        "name": "Diagnosis of T1DM",
        "previousId": "ec_1",
        "nextId": "ec_3"
      },
      {
        "id": "ec_3",
        "identifier": "3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion",
        "name": "Insulin Use",
        "previousId": "ec_2",
        "nextId": "ec_4"
      },
      {
        "id": "ec_4",
        "identifier": "4",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion",
        "name": "HbA1c Eligibility",
        "previousId": "ec_3",
        "nextId": "ec_5"
      },
      {
        "id": "ec_5",
        "identifier": "5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion",
        "name": "BMI Requirement",
        "previousId": "ec_4",
        "nextId": "ec_6"
      },
      {
        "id": "ec_6",
        "identifier": "6",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion",
        "name": "Age and Reproductive Status",
        "previousId": "ec_5"
      },
      {
        "id": "ec_7",
        "identifier": "1a",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion",
        "name": "History of T2DM",
        "nextId": "ec_8"
      },
      {
        "id": "ec_8",
        "identifier": "1b",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion",
        "name": "MODY History",
        "previousId": "ec_7",
        "nextId": "ec_9"
      },
      {
        "id": "ec_9",
        "identifier": "1c",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion",
        "name": "Pancreatic Disorders",
        "previousId": "ec_8",
        "nextId": "ec_10"
      },
      {
        "id": "ec_10",
        "identifier": "1d",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion",
        "name": "Previous SGLT-2 Use",
        "previousId": "ec_9",
        "nextId": "ec_11"
      },
      {
        "id": "ec_11",
        "identifier": "1e",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion",
        "name": "Insulin-sensitizing Agents",
        "previousId": "ec_10",
        "nextId": "ec_12"
      },
      {
        "id": "ec_12",
        "identifier": "1f",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion",
        "name": "GLP-1 Receptor Agonist Use",
        "previousId": "ec_11",
        "nextId": "ec_13"
      },
      {
        "id": "ec_13",
        "identifier": "1g",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_13",
        "instanceType": "EligibilityCriterion",
        "name": "Non-insulin Antihyperglycemic Use",
        "previousId": "ec_12",
        "nextId": "ec_14"
      },
      {
        "id": "ec_14",
        "identifier": "1h",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_14",
        "instanceType": "EligibilityCriterion",
        "name": "History of DKA",
        "previousId": "ec_13",
        "nextId": "ec_15"
      },
      {
        "id": "ec_15",
        "identifier": "1i",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_15",
        "instanceType": "EligibilityCriterion",
        "name": "Hospital Admission for Glycemic Control",
        "previousId": "ec_14",
        "nextId": "ec_16"
      },
      {
        "id": "ec_16",
        "identifier": "1j",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_16",
        "instanceType": "EligibilityCriterion",
        "name": "Severe Hypoglycemia Episodes",
        "previousId": "ec_15",
        "nextId": "ec_17"
      },
      {
        "id": "ec_17",
        "identifier": "1k",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_17",
        "instanceType": "EligibilityCriterion",
        "name": "Poorly Controlled Diabetes Symptoms",
        "previousId": "ec_16",
        "nextId": "ec_18"
      },
      {
        "id": "ec_18",
        "identifier": "1l",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_18",
        "instanceType": "EligibilityCriterion",
        "name": "Addison's or Adrenal Insufficiency",
        "previousId": "ec_17",
        "nextId": "ec_19"
      },
      {
        "id": "ec_19",
        "identifier": "1m",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_19",
        "instanceType": "EligibilityCriterion",
        "name": "Diabetes Insipidus",
        "previousId": "ec_18",
        "nextId": "ec_20"
      },
      {
        "id": "ec_20",
        "identifier": "2a",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_20",
        "instanceType": "EligibilityCriterion",
        "name": "Cardiovascular Disease",
        "previousId": "ec_19",
        "nextId": "ec_21"
      },
      {
        "id": "ec_21",
        "identifier": "2b",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_21",
        "instanceType": "EligibilityCriterion",
        "name": "Renal Disease",
        "previousId": "ec_20",
        "nextId": "ec_22"
      },
      {
        "id": "ec_22",
        "identifier": "2c",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_22",
        "instanceType": "EligibilityCriterion",
        "name": "Hepatic Diseases",
        "previousId": "ec_21",
        "nextId": "ec_23"
      },
      {
        "id": "ec_23",
        "identifier": "2d",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_23",
        "instanceType": "EligibilityCriterion",
        "name": "Hematological and Oncological Disease",
        "previousId": "ec_22",
        "nextId": "ec_24"
      },
      {
        "id": "ec_24",
        "identifier": "3a-c",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_24",
        "instanceType": "EligibilityCriterion",
        "name": "Liver Function Tests",
        "previousId": "ec_23",
        "nextId": "ec_25"
      },
      {
        "id": "ec_25",
        "identifier": "3d",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_25",
        "instanceType": "EligibilityCriterion",
        "name": "Creatinine Clearance",
        "previousId": "ec_24",
        "nextId": "ec_26"
      },
      {
        "id": "ec_26",
        "identifier": "3e",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_26",
        "instanceType": "EligibilityCriterion",
        "name": "Hemoglobin Levels",
        "previousId": "ec_25",
        "nextId": "ec_27"
      },
      {
        "id": "ec_27",
        "identifier": "3f",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_27",
        "instanceType": "EligibilityCriterion",
        "name": "Hepatitis Status",
        "previousId": "ec_26",
        "nextId": "ec_28"
      },
      {
        "id": "ec_28",
        "identifier": "3g",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_28",
        "instanceType": "EligibilityCriterion",
        "name": "Abnormal Free T4",
        "previousId": "ec_27",
        "nextId": "ec_29"
      },
      {
        "id": "ec_29",
        "identifier": "4a",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_29",
        "instanceType": "EligibilityCriterion",
        "name": "Allergies",
        "previousId": "ec_28",
        "nextId": "ec_30"
      },
      {
        "id": "ec_30",
        "identifier": "5a",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_30",
        "instanceType": "EligibilityCriterion",
        "name": "Pregnancy/Breastfeeding",
        "previousId": "ec_29",
        "nextId": "ec_31"
      },
      {
        "id": "ec_31",
        "identifier": "6a-b",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_31",
        "instanceType": "EligibilityCriterion",
        "name": "Incarceration",
        "previousId": "ec_30",
        "nextId": "ec_32"
      },
      {
        "id": "ec_32",
        "identifier": "6c-d",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_32",
        "instanceType": "EligibilityCriterion",
        "name": "Weight Loss/Exercise Programs",
        "previousId": "ec_31",
        "nextId": "ec_33"
      },
      {
        "id": "ec_33",
        "identifier": "6e",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_33",
        "instanceType": "EligibilityCriterion",
        "name": "Corticosteroid Therapy",
        "previousId": "ec_32",
        "nextId": "ec_34"
      },
      {
        "id": "ec_34",
        "identifier": "6f",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_34",
        "instanceType": "EligibilityCriterion",
        "name": "Unstable Disorders",
        "previousId": "ec_33",
        "nextId": "ec_35"
      },
      {
        "id": "ec_35",
        "identifier": "6g",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_35",
        "instanceType": "EligibilityCriterion",
        "name": "Volume Depletion",
        "previousId": "ec_34",
        "nextId": "ec_36"
      },
      {
        "id": "ec_36",
        "identifier": "6h-i",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_36",
        "instanceType": "EligibilityCriterion",
        "name": "Compliance and Medical Judgment",
        "previousId": "ec_35",
        "nextId": "ec_37"
      },
      {
        "id": "ec_37",
        "identifier": "6j",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_37",
        "instanceType": "EligibilityCriterion",
        "name": "Substance Abuse",
        "previousId": "ec_36",
        "nextId": "ec_38"
      },
      {
        "id": "ec_38",
        "identifier": "6k-l",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_38",
        "instanceType": "EligibilityCriterion",
        "name": "Investigator/Employee Conflict",
        "previousId": "ec_37",
        "nextId": "ec_39"
      },
      {
        "id": "ec_39",
        "identifier": "6m",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_39",
        "instanceType": "EligibilityCriterion",
        "name": "Other Investigational Drug",
        "previousId": "ec_38"
      }
    ],
    "summary": {
      "inclusionCount": 6,
      "exclusionCount": 33,
      "totalCount": 39
    },
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12",
        "ec_13",
        "ec_14",
        "ec_15",
        "ec_16",
        "ec_17",
        "ec_18",
        "ec_19",
        "ec_20",
        "ec_21",
        "ec_22",
        "ec_23",
        "ec_24",
        "ec_25",
        "ec_26",
        "ec_27",
        "ec_28",
        "ec_29",
        "ec_30",
        "ec_31",
        "ec_32",
        "ec_33",
        "ec_34",
        "ec_35",
        "ec_36",
        "ec_37",
        "ec_38",
        "ec_39"
      ],
      "instanceType": "StudyDesignPopulation",
      "description": "Target population defined by eligibility criteria"
    }
  },
  "rawResponse": {
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "name": "Informed Consent",
        "identifier": "1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_2",
        "name": "Diagnosis of T1DM",
        "identifier": "2",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_3",
        "name": "Insulin Use",
        "identifier": "3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_4",
        "name": "HbA1c Eligibility",
        "identifier": "4",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_5",
        "name": "BMI Requirement",
        "identifier": "5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_6",
        "name": "Age and Reproductive Status",
        "identifier": "6",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_7",
        "name": "History of T2DM",
        "identifier": "1a",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_8",
        "name": "MODY History",
        "identifier": "1b",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_9",
        "name": "Pancreatic Disorders",
        "identifier": "1c",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_10",
        "name": "Previous SGLT-2 Use",
        "identifier": "1d",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_11",
        "name": "Insulin-sensitizing Agents",
        "identifier": "1e",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_12",
        "name": "GLP-1 Receptor Agonist Use",
        "identifier": "1f",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_13",
        "name": "Non-insulin Antihyperglycemic Use",
        "identifier": "1g",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_13",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_14",
        "name": "History of DKA",
        "identifier": "1h",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_14",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_15",
        "name": "Hospital Admission for Glycemic Control",
        "identifier": "1i",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_15",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_16",
        "name": "Severe Hypoglycemia Episodes",
        "identifier": "1j",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_16",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_17",
        "name": "Poorly Controlled Diabetes Symptoms",
        "identifier": "1k",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_17",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_18",
        "name": "Addison's or Adrenal Insufficiency",
        "identifier": "1l",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_18",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_19",
        "name": "Diabetes Insipidus",
        "identifier": "1m",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_19",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_20",
        "name": "Cardiovascular Disease",
        "identifier": "2a",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_20",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_21",
        "name": "Renal Disease",
        "identifier": "2b",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_21",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_22",
        "name": "Hepatic Diseases",
        "identifier": "2c",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_22",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_23",
        "name": "Hematological and Oncological Disease",
        "identifier": "2d",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_23",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_24",
        "name": "Liver Function Tests",
        "identifier": "3a-c",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_24",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_25",
        "name": "Creatinine Clearance",
        "identifier": "3d",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_25",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_26",
        "name": "Hemoglobin Levels",
        "identifier": "3e",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_26",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_27",
        "name": "Hepatitis Status",
        "identifier": "3f",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_27",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_28",
        "name": "Abnormal Free T4",
        "identifier": "3g",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_28",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_29",
        "name": "Allergies",
        "identifier": "4a",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_29",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_30",
        "name": "Pregnancy/Breastfeeding",
        "identifier": "5a",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_30",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_31",
        "name": "Incarceration",
        "identifier": "6a-b",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_31",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_32",
        "name": "Weight Loss/Exercise Programs",
        "identifier": "6c-d",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_32",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_33",
        "name": "Corticosteroid Therapy",
        "identifier": "6e",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_33",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_34",
        "name": "Unstable Disorders",
        "identifier": "6f",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_34",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_35",
        "name": "Volume Depletion",
        "identifier": "6g",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_35",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_36",
        "name": "Compliance and Medical Judgment",
        "identifier": "6h-i",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_36",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_37",
        "name": "Substance Abuse",
        "identifier": "6j",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_37",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_38",
        "name": "Investigator/Employee Conflict",
        "identifier": "6k-l",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_38",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_39",
        "name": "Other Investigational Drug",
        "identifier": "6m",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_39",
        "instanceType": "EligibilityCriterion"
      }
    ],
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Informed Consent",
        "text": "Signed written Informed Consent: Subjects or their legally responsible representatives must be willing and able to give signed and dated written informed consent",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "Diagnosis of T1DM",
        "text": "Diagnosis of T1DM. In addition, the following criteria also needs to be met; i) Central laboratory test of C-peptide < 0.7 ng/ml (0.23 nmol/L)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Insulin Use",
        "text": "Insulin use for at least 12 months prior to screening per subject report or medical records and a) Method of insulin administration (MDI or CSII) must have been unchanged for at least 3 months prior to the screening visit per subject reported or medical records. Subjects must be taking a total insulin dose of ≥0.3 U/kg/day for at least 3 months prior to the screening visit b) If on MDI insulin administration, subject must be taking ≥3 injections per day",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "HbA1c Eligibility",
        "text": "HbA1c eligibility criteria include: a) Screening visit: Central laboratory HbA1c ≥7.7% and ≤11.0% b) Week -1 Visit: Central laboratory HbA1c ≥7.5 % and ≤10.5%",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "BMI Requirement",
        "text": "Body mass index (BMI) ≥18.5 kg/m²",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "Age and Reproductive Status",
        "text": "Men and women, ages 18 to 75 years, inclusive. Women of childbearing potential (WOCBP) must have a negative serum or urine pregnancy test within 24 hours prior to the start of investigational product. Women must not be breastfeeding. WOCBP and sexually active males must agree to follow instructions for method(s) of contraception.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "History of T2DM",
        "text": "History of T2DM. Note: subjects with a previous misdiagnosis of T2DM in their medical history must have one of the following in order to be eligible for this trial: Positive autoantibodies for GAD65, phosphatase IA-2/IA2β, or zinc transporter 8 (ZnT8) or Fasting c-peptide value below the lower limit of detection performed by the Central Laboratory",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "MODY History",
        "text": "History of maturity-onset diabetes of the young (MODY)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Pancreatic Disorders",
        "text": "Pancreatic surgery, chronic pancreatitis, or other pancreatic disorders that could result in decreased β-cell capacity (eg, pancreatogenous diabetes)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Previous SGLT-2 Use",
        "text": "Previous use of dapagliflozin and/or any other SGLT-2 inhibitors",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Insulin-sensitizing Agents",
        "text": "Use of insulin-sensitizing agents, such as metformin and/or thiazolidinediones, within 2 months prior to the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "GLP-1 Receptor Agonist Use",
        "text": "Use of any GLP-1 receptor agonist within the following timeframe prior to the screening visit: 1 month for once or twice daily administration (eg, liraglutide); 2 months for once weekly administration",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_13",
        "name": "Non-insulin Antihyperglycemic Use",
        "text": "Use of any non-insulin antihyperglycemic agent within 1 month prior to the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_14",
        "name": "History of DKA",
        "text": "History of DKA requiring medical intervention (eg, emergency room visit and/or hospitalization) within 1 month prior to the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_15",
        "name": "Hospital Admission for Glycemic Control",
        "text": "History of hospital admission for glycemic control (either hyperglycemia or hypoglycemia) within 1 month prior to the Screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_16",
        "name": "Severe Hypoglycemia Episodes",
        "text": "Frequent episodes of severe hypoglycemia as defined by more than one episode requiring medical assistance, emergency care (paramedics or emergency room care), and/or glucagon therapy administered by a third-party individual within 1 month prior to the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_17",
        "name": "Poorly Controlled Diabetes Symptoms",
        "text": "Symptoms of poorly controlled diabetes that would preclude participation in this trial including, but not limited to, marked polyuria and polydipsia with greater than 10% weight loss during the 3 months prior to the screening visit, or other signs and symptoms of poor glycemic control",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_18",
        "name": "Addison's or Adrenal Insufficiency",
        "text": "History of Addison’s disease or chronic adrenal insufficiency",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_19",
        "name": "Diabetes Insipidus",
        "text": "History of diabetes insipidus",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_20",
        "name": "Cardiovascular Disease",
        "text": "Any of the following cardiovascular (CV)/vascular disease within 6 months of the screening visit: Myocardial infarction, Cardiac surgery or revascularization, Unstable angina, Unstable congestive heart failure (CHF), NYHA CHF Class III or IV, TIA or significant cerebrovascular disease, Unstable or previously undiagnosed arrhythmia",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_21",
        "name": "Renal Disease",
        "text": "Renal disease: History of unstable or rapidly progressing renal disease; Conditions of congenital renal glucosuria; Renal allograft",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_22",
        "name": "Hepatic Diseases",
        "text": "Significant hepatic disease, including, but not limited to, chronic active hepatitis and/or severe hepatic insufficiency",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_23",
        "name": "Hematological and Oncological Disease",
        "text": "History of hemoglobinopathy (except sickle cell trait or thalassemia minor); Known immunocompromised status; Donation of blood > 400 mL within 8 weeks; Malignancy within 5 years; History of bladder cancer; History of radiation therapy to the lower abdomen or pelvis",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_24",
        "name": "Liver Function Tests",
        "text": "Aspartate aminotransferase (AST) > 3x ULN; Alanine aminotransferase (ALT) > 3x ULN; Serum total bilirubin (TB) > 2x ULN unless exclusively caused by Gilbert’s Syndrome",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_25",
        "name": "Creatinine Clearance",
        "text": "Calculated creatinine clearance (CrCl) < 60 mL/min as estimated by the Cockcroft-Gault formula at the screening visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_26",
        "name": "Hemoglobin Levels",
        "text": "Hemoglobin ≤11.0 g/dL (110 g/L) for men; hemoglobin ≤10.0 g/dL (100 g/L) for women",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_27",
        "name": "Hepatitis Status",
        "text": "Positive for hepatitis B surface antigen or anti-hepatitis C virus antibody",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_28",
        "name": "Abnormal Free T4",
        "text": "Abnormal Free T4 (abnormal TSH value at enrollment will be further evaluated for free T4)",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_29",
        "name": "Allergies",
        "text": "Allergies or contraindication to the contents of dapagliflozin tablets or insulin",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_30",
        "name": "Pregnancy/Breastfeeding",
        "text": "Women who are pregnant or breastfeeding",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_31",
        "name": "Incarceration",
        "text": "Prisoners or subjects who are involuntarily incarcerated; Subjects who are compulsorily detained for treatment of either a psychiatric or physical illness",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_32",
        "name": "Weight Loss/Exercise Programs",
        "text": "Subjects on a commercial weight loss program with ongoing weight loss, or on an intensive exercise program; History of bariatric surgery or lap-band procedure within 12 months prior to screening",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_33",
        "name": "Corticosteroid Therapy",
        "text": "Replacement or chronic systemic corticosteroid therapy, defined as any dose of systemic corticosteroid (including local injections) taken for > 4 weeks within 3 months prior to the Day 1 visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_34",
        "name": "Unstable Disorders",
        "text": "Any unstable endocrine, psychiatric or rheumatic disorders as judged by the investigator",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_35",
        "name": "Volume Depletion",
        "text": "Volume-depleted subjects. Subjects at risk for volume depletion due to co-existing conditions or concomitant medications who cannot carefully monitor their volume status",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_36",
        "name": "Compliance and Medical Judgment",
        "text": "Subject who, in the judgment of the investigator, is found to be unlikely to comply with the protocol, or is unable to correctly administer subcutaneous insulin injections and/or manage their insulin pump, or has any severe concurrent medical or psychological condition",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_37",
        "name": "Substance Abuse",
        "text": "Subject is currently abusing alcohol or other drugs or has done so within the last 6 months prior to the Day 1 visit",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_38",
        "name": "Investigator/Employee Conflict",
        "text": "Subject is a participating investigator, study coordinator, employee of an investigator, or employee of BMS/AstraZeneca",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_39",
        "name": "Other Investigational Drug",
        "text": "Administration of any other investigational drug within 30 days of the screening visit",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "plannedEnrollmentNumber": {
        "maxValue": 768,
        "instanceType": "Range"
      },
      "plannedMinimumAge": "P18Y",
      "plannedMaximumAge": "P75Y",
      "plannedSex": [
        {
          "code": "Male",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Male"
        },
        {
          "code": "Female",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Female"
        }
      ],
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12",
        "ec_13",
        "ec_14",
        "ec_15",
        "ec_16",
        "ec_17",
        "ec_18",
        "ec_19",
        "ec_20",
        "ec_21",
        "ec_22",
        "ec_23",
        "ec_24",
        "ec_25",
        "ec_26",
        "ec_27",
        "ec_28",
        "ec_29",
        "ec_30",
        "ec_31",
        "ec_32",
        "ec_33",
        "ec_34",
        "ec_35",
        "ec_36",
        "ec_37",
        "ec_38",
        "ec_39"
      ],
      "instanceType": "StudyDesignPopulation"
    }
  }
}